India Urologic Oncology Market Size & Growth Rate
According to 6Wresearch internal database and industry insights, the India Urologic Oncology Market was valued at USD 637.0 million in 2025 and is projected to reach USD 1,043.13 million by 2032, growing at a CAGR of approximately 7.3% during 2026–2032.
India Urologic Oncology Market Highlights
| Report Metric | Details |
| Report Name | India Urologic Oncology Market |
| Market Size 2025 | USD 637.0 million |
| Market Size 2032 | USD 1,043.13 million |
| Absolute Growth 2025–2032 | USD 406.13 million |
| CAGR 2026–2032 | 7.3% |
| Peak Annual Growth | 9.5% in 2026 |
| Forecast Period | 2026–2032 |
| Historical Data | 2022–2025 |
| Base Year | 2025 |
| Leading Specialty Area, 2025 | Drug Therapy (47% share) |
| Leading Intervention Method, 2025 | Robotic Surgery (34% share) |
| Leading Technology Used, 2025 | AI-Enabled Diagnostics (52% share) |
| Leading End User, 2025 | Hospitals (41% share) |
| Fastest-Growing Specialty Area | Advanced Imaging (9.3% CAGR) |
| Fastest-Growing Intervention Method | Targeted Drugs (9.6% CAGR) |
| Fastest-Growing End User | Oncology Centers (9.7% CAGR) |
| Growing Sector | Oncology Centers |
| Key End Users | Hospitals, Oncology Centers, Cancer Clinics, Urology Units |
India Urologic Oncology Market Year-wise Growth Rate and Key Drivers (2022–2032)
This graph illustrates the annual growth rates of the market from 2022 to 2032, highlighting a steady upward trajectory and projected market expansion over the forecast period.
The following table presents the estimated annual growth rate for each year together with the principal factor influencing market performance.
| Year | Estimated Annual Growth (%) | Market Rationale |
| 2022 | 7.3 | The market showed steady growth, driven by the National Cancer Registry Programme's focus on rising cancer cases and treatment demand from hospitals. |
| 2023 | 5.0 | Growth slowed due to a temporary dip in hospital admissions for elective procedures, impacting treatment volumes in oncology centers. |
| 2024 | 8.1 | A surge in minimally invasive surgeries boosted growth rates as hospitals adopted advanced techniques outlined by the Indian Society of Oncology. |
| 2025 | 5.1 | The market continued to grow, albeit at a slower pace, as hospitals adjusted to new treatment protocols established by the National Cancer Control Programme. |
| 2026 | 9.5 | An increase in investment in robotic surgery technology is expected to peak growth this year, enhancing surgical precision. |
| 2027 | 6.7 | Growth is projected to slow as hospitals face challenges in integrating new technologies effectively, particularly in urban areas. |
| 2028 | 8.7 | The market is expected to rebound with advancements in imaging technologies improving treatment accuracy in oncology centers. |
| 2029 | 7.2 | Growth is projected to slow again as competition among service providers intensifies in urban areas with multiple oncology centers. |
| 2030 | 6.4 | The market will continue to grow, supported by ongoing investments in cancer care infrastructure driven by government initiatives. |
| 2031 | 6.9 | A slight increase in growth is expected as patient awareness of treatment options improves through public health campaigns. |
| 2032 | 5.8 | Growth is projected to slow as the market matures and competition stabilises in the urologic oncology sector. |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
India Urologic Oncology Market Synopsis
Urologic Oncology in India involves diagnosing and treating cancers that affect the urinary system and male reproductive organs. This field encompasses surgical, radiation, and pharmaceutical interventions, driven by strong demand from hospitals and oncology centres. The India Urologic Oncology Market is expanding due to rising cancer incidences, particularly prostate and bladder cancers, alongside increased investments in advanced treatment technologies. The National Cancer Control Programme and the integration of AI-enabled diagnostics are key contributors to this growth, with over 1.4 million new cancer cases reported each year.
Market Dynamics Impact Analysis (2026–2032)
| Factor | Type | Impact | Primary Segment Affected |
| Rising cancer incidences are increasing the need for urologic oncology services. | Driver | High | Hospitals |
| Investment in robotic surgery is enhancing treatment precision and outcomes. | Driver | High | Robotic Surgery |
| The growing number of oncology centres is expanding access to specialized care. | Opportunity | High | Oncology Centers |
| Increased demand for targeted therapies offers a chance for new entrants. | Opportunity | High | Drug Therapy |
| Limited access to advanced therapies in rural areas restricts market growth. | Restraint | High | Radiation Oncology |
| High costs of advanced treatment technologies can deter patient uptake. | Restraint | Medium | Advanced Imaging |
| The Urologic Oncology market in India faces a few practical problems, including high treatment costs. | Challenge | High | Drug Therapy |
| Integration of new technologies into existing systems presents operational challenges. | Challenge | Medium | Robotic Surgery |
Evaluation of Drivers in India Urologic Oncology Market (2026–2032)
Key forces behind demand, with the segment each one moves most, are listed below.
| Drivers | Primary Segment Affected | Why It Matters (Evidence) |
| Increasing cancer cases drive demand for urologic oncology services. | Hospitals | India reports over 1.4 million new cancer cases annually, leading to higher patient volumes seeking treatment. |
| Investment in robotic surgery improves precision in surgical procedures. | Robotic Surgery | Minimally invasive surgeries have increased by 30% in major hospitals, improving recovery times and attracting more patients. |
| The rise of oncology centres expands access to specialized cancer care. | Oncology Centers | The National Cancer Control Programme aims to improve cancer care infrastructure across India, increasing patient access. |
| Growing adoption of AI-enabled diagnostics improves treatment accuracy. | AI-Enabled Diagnostics | AI-enabled diagnostics are projected to be integrated into 50% of oncology centres by 2025, enhancing diagnostic capabilities. |
| Targeted therapies are increasingly used in treatment protocols. | Drug Therapy | Over 60% of prostate cancer patients are now receiving targeted therapies in their treatment, reflecting a shift in approach. |
The Urologic Oncology market in India is growing on the back of rising cancer incidences, expanding healthcare infrastructure, and increasing investments in advanced treatment technologies. With over 1.4 million new cancer cases annually, hospitals are compelled to improve their oncology services to meet demand. Investment in robotic surgery is expected to improve surgical precision, attracting more patients seeking advanced care. The integration of AI-enabled diagnostics into oncology centres will enhance treatment accuracy and patient outcomes. The rise of oncology centres is expanding access to specialized cancer care, further stimulating demand for urologic oncology services across the country.
Evaluation of Restraints in India Urologic Oncology Market
Below mentioned are some major restraints and their influence on market dynamics.
| Market Restraint | Primary Segment Affected | Why It Matters (Evidence) |
| Limited access to advanced therapies in rural areas restricts market growth. | Radiation Oncology | Over 500 centres offer radiation therapy, but many rural areas remain underserved, limiting patient options. |
| High costs of advanced treatment technologies can deter patient uptake. | Advanced Imaging | Patients may avoid expensive imaging techniques, impacting overall treatment outcomes and access to care. |
| Regulatory hurdles can delay the introduction of new therapies. | Drug Therapy | Stringent approval processes can slow the launch of new cancer treatments, affecting availability for patients. |
| Competition among service providers can lead to price wars, affecting profitability. | Oncology Centers | Urban areas see multiple oncology centres vying for the same patient base, driving prices down. |
| Limited awareness of treatment options can hinder patient access to care. | Hospitals | Many patients remain unaware of available urologic oncology services and technologies, delaying treatment. |
India Urologic Oncology Market Challenges
The India urologic oncology market faces several practical issues, starting with a shortage of skilled healthcare professionals. This challenge stems from a lack of comprehensive training programmes, resulting in treatment delays for patients, especially in rural areas where specialists are scarce. Lengthy regulatory approval processes for new therapies can take up to three years, limiting advanced treatment options for hospitals and oncology centres. High costs present another hurdle, with prostate cancer treatment averaging over ₹1 lakh, making it unaffordable for many patients. Supply chain disruptions further complicate the situation, affecting the availability of essential drugs and technologies, which delays treatment for clinics and hospitals nationwide.
Trends in the India Urologic Oncology Market
Below mentioned are some of the trends shaping the India Urologic Oncology Market growth.
- Shift to Minimally Invasive Procedures: The National Cancer Control Programme has encouraged a shift towards minimally invasive surgeries, which have increased by 30% in major hospitals over the last five years. This trend improves patient recovery and reduces hospital stays.
- Integration of AI in Diagnostics: Since 2021, AI-enabled diagnostics have been increasingly adopted in oncology centres, with projections showing integration in 50% of facilities by 2025. This shift improves diagnostic accuracy and treatment planning.
- Growth of Targeted Therapies: Targeted therapies are now included in treatment protocols for over 60% of prostate cancer patients, reflecting a shift in treatment approaches since 2020. This trend allows for more personalised patient care.
- Expansion of Oncology Centres: The establishment of new oncology centres, particularly in urban areas, has increased access to specialised care. This expansion is part of the National Cancer Control Programme's efforts to improve cancer care infrastructure.
Investment Opportunities in the India Urologic Oncology Market
Several openings in the India Urologic Oncology Market merit attention from investors.
- Urban Hospitals: Urban hospitals are expanding their oncology services to meet rising demand, with over 1.4 million new cancer cases annually. Investing in advanced imaging technologies can improve patient care and attract more patients.
- Joint Ventures for Advanced Technologies: Collaborating with local hospitals through joint ventures can facilitate the introduction of advanced treatment technologies. This approach is particularly beneficial in urban centres where demand is growing rapidly.
- Oncology Centres in Rural Areas: Oncology centres are needed in rural areas to improve access to cancer care. With the National Health Mission's initiatives, there is an opportunity to invest in these facilities to enhance local healthcare.
- Targeted Drug Supply: Supplying targeted drugs to hospitals can meet the growing demand for personalised treatment approaches. With over 60% of prostate cancer patients receiving these therapies, the market is ripe for investment.
Government Initiatives in the India Urologic Oncology Market
The Ministry of Health and Family Welfare launched the National Cancer Control Programme in 2020 to improve cancer care infrastructure across India. This initiative focuses on enhancing access to treatment and reducing cancer mortality rates. The Department of Health Research initiated a scheme in 2021 to fund research in urologic oncology with a budget of ₹300 million, supporting advancements in treatment methodologies. Additionally, the National Medical Commission updated guidelines in 2022 for the training of urologists in advanced oncology techniques, ensuring a skilled workforce for the future.
The Indian Council of Medical Research has allocated ₹500 million for cancer care initiatives to improve access to treatment in rural areas. This funding aims to enhance infrastructure and services for underserved populations. The Indian Council of Medical Research launched a national registry for cancer patients in 2023 to improve treatment outcomes, providing valuable data for ongoing research and policy development. These measures collectively support the growth of the urologic oncology market by ensuring better access and quality of care.
Future Insight of the India Urologic Oncology Market
The India urologic oncology market will evolve significantly by 2032, driven by advancements in treatment protocols and technology integration. The National Cancer Control Programme will improve access to care, especially in rural areas. By 2025, AI diagnostics will be implemented in half of the oncology centers, enhancing early detection and patient outcomes. Additionally, the integration of proton beam therapy in select metropolitan hospitals will provide patients with more advanced treatment options, while the government's commitment to immuno-oncology research will stimulate innovation and broaden therapeutic avenues.
Market Segmentation Analysis
The report offers a comprehensive study of the following market segments and their leading categories in the market.
By Specialty Area – Drug Therapy Dominated, Advanced Imaging Expected to Grow Fastest
According to Bhawna Singh, Assistant Manager at 6Wresearch, in 2025, Drug Therapy led the specialty area split with a 47% share. Drug therapy holds a leading share in the India Urologic Oncology Market due to its essential role in managing urologic cancers, particularly prostate and bladder cancers. The increasing incidence of these cancers, as reported by the National Cancer Registry Programme, drives hospitals to rely heavily on effective drug treatments. Advanced Imaging is set to record the highest CAGR in this split, 9.3% over 2026–2032. The rapid growth of advanced imaging is fuelled by the rising demand for accurate diagnostic tools, evidenced by a 30% increase in minimally invasive surgeries in major hospitals over the last five years. This trend highlights the critical need for advanced imaging technologies to ensure precise treatment planning. This suggests that suppliers should focus on enhancing drug therapy offerings while also investing in advanced imaging technologies to meet the evolving market needs.
By Intervention Method – Robotic Surgery Dominated, Targeted Drugs Expected to Grow Fastest
With a 34% revenue share in 2025, Robotic Surgery was the largest intervention method category. Robotic surgery is the dominant intervention method in the India Urologic Oncology Market, as it significantly enhances precision in surgical procedures for urologic cancers. The increasing adoption of robotic systems in hospitals reflects the growing demand for advanced surgical techniques that improve patient outcomes. Targeted Drugs are projected to grow fastest, at a CAGR of 9.6% during 2026–2032. The targeted drugs segment is witnessing rapid growth, driven by the rising incorporation of personalised treatment approaches in oncology. With over 60% of prostate cancer patients now receiving targeted therapies, this method is becoming increasingly vital in treatment protocols. For suppliers, this means a strategic focus on robotic surgery technologies and targeted drug development is essential to capture market opportunities.
By Technology Used – AI-Enabled Diagnostics Dominated and Is Expected to Record the Fastest Growth
The largest technology used category in 2025 was AI-Enabled Diagnostics, with a 52% share of total revenue. AI-enabled diagnostics leads the technology segment in the India Urologic Oncology Market, as it plays a crucial role in supporting accurate diagnosis and treatment planning. The integration of AI technologies into 50% of oncology centers by 2025 demonstrates the growing reliance on these advanced diagnostic tools. AI-Enabled Diagnostics are also forecast to expand faster than any other category, at a CAGR of 9.3% over 2026–2032. AI-enabled diagnostics is also the fastest-growing technology, reflecting its increasing importance in enhancing diagnostic accuracy and treatment effectiveness. The ongoing integration of AI in oncology practices signifies a transformative shift towards data-driven healthcare solutions. This indicates that suppliers should prioritise the development and deployment of AI-enabled diagnostic tools to stay competitive in the market.
By End User – Hospitals Dominated, Oncology Centers Expected to Grow Fastest
Hospitals held a 41% share of the India Urologic Oncology Market by end user in 2025. Hospitals dominate the end-user segment in the India Urologic Oncology Market, serving as the primary providers of urologic oncology services. With over 1.4 million new cancer cases annually, hospitals are pivotal in delivering comprehensive cancer care to a growing patient population. The quickest growth will come from Oncology Centers, forecast to expand at a CAGR of 9.7% between 2026 and 2032. Oncology centers represent the fastest-growing end-user segment, driven by the increasing demand for specialised cancer treatment facilities. As more patients seek targeted therapies and advanced treatment options, oncology centers are expanding their services to meet these needs. This highlights the necessity for suppliers to strengthen partnerships with hospitals and oncology centers to effectively address the rising demand for urologic oncology services.
Key Attractiveness of the Report
- 10 Years of Market Numbers
- Historical Data Starting from 2022 to 2025
- Base Year 2025
- Forecast Data until 2032
- Key Performance Indicators Impacting the Market
- Major Upcoming Developments and Projects
Key Highlights of the Report:
- India Urologic Oncology Market Outlook
- Market Size of India Urologic Oncology Market, 2025
- Forecast of India Urologic Oncology Market, 2032
- Historical Data and Forecast of India Urologic Oncology Revenues & Volume for the Period 2022 - 2032F
- India Urologic Oncology Market Trend Evolution
- India Urologic Oncology Market Drivers and Challenges
- India Urologic Oncology Price Trends
- India Urologic Oncology Porter's Five Forces
- India Urologic Oncology Industry Life Cycle
- Historical Data and Forecast of India Urologic Oncology Market Revenues & Volume By Specialty Area for the Period 2022 - 2032F
- Historical Data and Forecast of India Urologic Oncology Market Revenues & Volume By Minimally Invasive for the Period 2022 - 2032F
- Historical Data and Forecast of India Urologic Oncology Market Revenues & Volume By Advanced Imaging for the Period 2022 - 2032F
- Historical Data and Forecast of India Urologic Oncology Market Revenues & Volume By Drug Therapy for the Period 2022 - 2032F
- Historical Data and Forecast of India Urologic Oncology Market Revenues & Volume By Radiation Oncology for the Period 2022 - 2032F
- Historical Data and Forecast of India Urologic Oncology Market Revenues & Volume By Intervention Method for the Period 2022 - 2032F
- Historical Data and Forecast of India Urologic Oncology Market Revenues & Volume By Robotic Surgery for the Period 2022 - 2032F
- Historical Data and Forecast of India Urologic Oncology Market Revenues & Volume By PET/CT Scans for the Period 2022 - 2032F
- Historical Data and Forecast of India Urologic Oncology Market Revenues & Volume By Targeted Drugs for the Period 2022 - 2032F
- Historical Data and Forecast of India Urologic Oncology Market Revenues & Volume By External Beam Therapy for the Period 2022 - 2032F
- Historical Data and Forecast of India Urologic Oncology Market Revenues & Volume By Technology Used for the Period 2022 - 2032F
- Historical Data and Forecast of India Urologic Oncology Market Revenues & Volume By Laparoscopic Systems for the Period 2022 - 2032F
- Historical Data and Forecast of India Urologic Oncology Market Revenues & Volume By AI-Enabled Diagnostics for the Period 2022 - 2032F
- Historical Data and Forecast of India Urologic Oncology Market Revenues & Volume By Immuno-oncology Agents for the Period 2022 - 2032F
- Historical Data and Forecast of India Urologic Oncology Market Revenues & Volume By Proton Beam for the Period 2022 - 2032F
- Historical Data and Forecast of India Urologic Oncology Market Revenues & Volume By End User for the Period 2022 - 2032F
- Historical Data and Forecast of India Urologic Oncology Market Revenues & Volume By Hospitals for the Period 2022 - 2032F
- Historical Data and Forecast of India Urologic Oncology Market Revenues & Volume By Oncology Centers for the Period 2022 - 2032F
- Historical Data and Forecast of India Urologic Oncology Market Revenues & Volume By Cancer Clinics for the Period 2022 - 2032F
- Historical Data and Forecast of India Urologic Oncology Market Revenues & Volume By Urology Units for the Period 2022 - 2032F
- India Urologic Oncology Import Export Trade Statistics
- Market Opportunity Assessment By Specialty Area
- Market Opportunity Assessment By Intervention Method
- Market Opportunity Assessment By Technology Used
- Market Opportunity Assessment By End User
- India Urologic Oncology Top Companies Market Share
- India Urologic Oncology Competitive Benchmarking By Technical and Operational Parameters
- India Urologic Oncology Company Profiles
- India Urologic Oncology Key Strategic Recommendations
Market Covered
This report examines the market across the segments below.
By Specialty Area
- Minimally Invasive
- Advanced Imaging
- Drug Therapy
- Radiation Oncology
By Intervention Method
- Robotic Surgery
- PET/CT Scans
- Targeted Drugs
- External Beam Therapy
By Technology Used
- Laparoscopic Systems
- AI-Enabled Diagnostics
- Immuno-oncology Agents
- Proton Beam
By End User
- Hospitals
- Oncology Centers
- Cancer Clinics
- Urology Units
